SchoolCare vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
HIPAA/FERPA-compliant school health EHR for K–12 nurse offices, serving 1M+ students across 2,000+ schools in 30 states; rebranded from CareDox; $91.9M raised.
About
SchoolCare (formerly CareDox) is a digital health technology company that partners with K–12 school nurse offices to provide HIPAA- and FERPA-compliant electronic health records, chronic disease management tools, and immunization compliance reporting. The company was founded under the CareDox name and rebranded to SchoolCare to better reflect its exclusive focus on the school health setting. SchoolCare's platform enables school nurses to document student health visits, manage chronic conditions (such as asthma, diabetes, and food allergies), track medication administration, and communicate securely with families — replacing paper-based systems that create compliance risks and administrative burden in school districts.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.